Risk of Dementia in Patients with Leptospirosis: A Nationwide Cohort Analysis
Open Access
- 30 August 2019
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 16 (17) , 3168
Abstract
Background: Studies have linked some bacterial infections with an increased likelihood for development of dementia. However, there is a paucity of data on the relationship between dementia and leptospirosis. In view of this, we conducted a retrospective cohort study to determine whether leptospirosis is a risk factor for dementia. Methods: Data were collected from the Taiwan National Health Insurance Research Databases (2000–2010) to investigate the incidence of and risk factors for dementia in patients with leptospirosis. Patients with leptospirosis who did not have a history of dementia were enrolled in the study. For each leptospirosis patient, four controls were randomly selected after frequency matching of age, sex, and index date. Cox proportional hazard regression models were used for the analyses of dementia risk. Results: A greater risk of dementia was observed in the leptospirosis cohort than in the non-leptospirosis cohort both in patients without any comorbidity (adjusted HR (aHR) = 1.23, 95% CI = 1.06–1.43) and with a comorbidity (aHR = 2.06, 95% CI = 1.7–2.5). Compared with the non-leptospirosis cohort without these comorbidities, the leptospirosis cohort with ≥2 comorbidities exhibited a significantly increased risk of dementia (aHR = 6.11, 95% CI = 3.15–11.9), followed by those with any one comorbidity (adjusted HR = 3.62, 95% CI = 1.76–7.46). Conclusions: Patients with leptospirosis were at a 1.89-fold greater risk of subsequent dementia, but potential genetic susceptibility bias in the study group is a major confound.Keywords
Funding Information
- Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW108-TDU-B-212-133004)
- Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM104010092)
- NRPB Stroke Clinical Trial Consortium (MOST 108-2321-B-039-003-)
- Tungs' Taichung MetroHarbor Hospital (TTMHH-108R0029)
- Tseng-Lien Lin Foundation (not applicable.)
- Taoyuan Armed Forces General Hospital, Taiwan (AFTYGH-10718)
- Katsuzo and Kiyo Aoshima Memorial Funds (not applicable.)
This publication has 50 references indexed in Scilit:
- Fool's Gold: Why Imperfect Reference Tests Are Undermining the Evaluation of Novel Diagnostics: A Reevaluation of 5 Diagnostic Tests for LeptospirosisClinical Infectious Diseases, 2012
- Vascular Contributions to Cognitive Impairment and DementiaStroke, 2011
- Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteriaJournal of Neuroinflammation, 2011
- Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative‐induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapyThe FASEB Journal, 2011
- Leptospirosis: risks during recreational activitiesJournal of Applied Microbiology, 2009
- Prevention of Alzheimer's disease and dementia. Major findings from the Kungsholmen ProjectPhysiology & Behavior, 2007
- Sex Differences in Clinical Leptospirosis in Germany: 1997-2005Clinical Infectious Diseases, 2007
- Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expressionProceedings of the National Academy of Sciences, 2006
- Alzheimer Disease as a Vascular DisorderStroke, 2002
- Assessment of the Clinical Presentation and Treatment of 353 Cases of Laboratory‐Confirmed Leptospirosis in Hawaii, 1974–1998Clinical Infectious Diseases, 2001